More Topics:
United Therapeutics CEO Rothblatt Buys $1.6M in December – cbl
Posted December 11, 2011
We Recommend...
Martine Rothblatt
By Brian Wolak
SILVER SPRING, Md. -- Martine Rothblatt has bought $1.62 million in United Therapeutics (Nasdaq:UTHR) stock since the beginning of December as part of a pre-arranged trading plan.
Rothblatt, chairman and CEO, purchased 38,687 shares over numerous transactions at an average price of $41.84 a share.
United Therapeutics closed at $42.02 on Friday. The stock is down more than 33 percent year to date.
Altogether, Rothblatt holds 605,750 shares in her trust, worth $25.45 million.
Rothblatt founded United Therapeutics in 1996 and has served as chairman and CEO since its inception. Prior to United Therapeutics, she founded and served as chairman and CEO of Sirius Satellite Radio.
Silver Spring, Md.-based United Therapeutics makes products for patients with chronic and life-threatening diseases.
The company recently embarked on a $300 million share repurchase program using proceeds from an offering of $250 million of 1.0 percent convertible senior notes due in 2016.
SEC filing: http://tinyurl.com/cvl5lvn
United Therapeutics
![](http://app.quotemedia.com/quotetools/getChart?webmasterId=91233&symbol=UTHR&chscale=10d"eBox=true&chtype=FinancialAreaChart&chwid=530&chhig=350&chfill=ee03479c&chfill2=1103479c&chln=03479c&chpccol=ff0000&chfrmon=false&chton=false&chpcon=true)
To find out more about the company in this article and to see if you
have business connections, click below:
blog comments powered by